Assignment
Evidence-based medicine (EBM), previously translational medicine, can be defined as improving care based on empirical research and/or hands-on practice. The EBM's approach is based on either direct patient care (bottom-up) or an experiment translated into guidelines (top-down). EBM is used in either in conjunction or as quality assessment tool(s) for continuous quality improvement (CQI). The healthcare leader must utilize the evidence to promote healthcare quality.
• Explain the process of evidence-based analysis.
• Highlight the major players and their roles in EBM policy (i.e., government, providers, patients, etc.).
• Explain the EBM "Levels of Evidence" as defined in your course text.
• Review the case "Constraints of the ACA on Evidence-Based Medicine."
• Provide a written analysis of the case "Constraints of the ACA on Evidence-Based Medicine" (Utilize the "Levels of Evidence and Grades of Recommendations" as defined by the National Guideline) Clearinghouse.
• Summarize the policy of EBM in your conclusion.
The paper
• Must be 3 double-spaced pages in length (not including title and reference pages) and formatted according to APA style.
• Must include a separate title page with the following:
o Title of paper
o Student's name
o Course name and number
o Instructor's name
o Date submitted
• Must use at least five scholarly sources in addition to the course text.
REFERENCE FOR THE CASE
McLaughlin, C. P., & McLaughlin, C. D. (2014). Health Policy Analysis: An interdisciplinary approach (2nd ed.). Sudbury, MA: Jones and Bartlett Publishers. Print ISBN: 9781284037777.